Proceedings of the Ninth International Conference of Drug Regulatory Authorities (ICDRA) - Berlin, Germany 25-29 April 1999
(1999; 102 pages) View the PDF document
Table of Contents
Open this folder and view contentsOpening Ceremony
Open this folder and view contentsGood regulatory practice
Open this folder and view contentsGood certification practice
Open this folder and view contentsCounterfeit drugs: challenges and solutions
Open this folder and view contentsCurrent issues in regulation and quality
Close this folderInternational Conference on Harmonization: implementation and implications
View the documentIntroduction to the ICH
View the documentNon-ICH country perspective: Egypt
View the documentNon-ICH country perspective: Australia
View the documentRecommendations
Open this folder and view contentsDrug utilization studies
Open this folder and view contentsInternational Conference on Harmonization and the common technical document
Open this folder and view contentsKeynote address
Open this folder and view contentsGlobal and national efforts to reduce tobacco use
Open this folder and view contentsElectronic communication in the regulatory process
Open this folder and view contentsTransparency in monitoring the safety of medicines
Open this folder and view contentsPharmaceutical products for use in special groups
Open this folder and view contentsNeed for Bioequivalence
Open this folder and view contentsAntimicrobial resistance: battling the bugs
Open this folder and view contentsSafety issues of plasma-derived medicinal products
Open this folder and view contentsHerbal medicines
Open this folder and view contentsRegulation and access to essential drugs
View the documentParticipants
View the documentBack cover
 

International Conference on Harmonization: implementation and implications

Moderators: Mr F. Sauer, European Union

The purpose of the International Conference on Harmonization (ICH) is to eliminate duplicative regulatory requirements, use resources more efficiently and ensure quicker access to safe, effective and good quality new pharmaceutical products. A total of 43 ICH guidelines have been published covering quality, efficacy and safety. Future activities will focus on implementation of the Common Technical Document (CTD) which is that part in documentation of a new drug application which will be basically the same in all ICH countries. New guidelines will be developed on emerging new issues that require harmonization and current guidelines will be updated as required. ICH countries have promised to help in globalization of ICH products by offering direct assistance to non-ICH countries and through co-operation with WHO. ICH wishes to serve as a resource of information by organizing conferences and seminars and by publishing guidelines on its Website.

to previous section to next section
 

Last updated: April 24, 2012